723 Metabolically reprogrammed autologous Th1/Tc1 cell therapy (RAPA-201) yields promising safety and efficacy in post-PD-(L)1 solid tumor patients without lymphodepleting host conditioning

Lawrence G Lum,Martin Gutierrez, Sunil Patel, Michele Donato,Jee Hyun Park,Tania Felizardo,Daniel H Fowler, Morgan Finlay, Ronit Reich-Slotky, Research Nurse Coordinator

Journal for ImmunoTherapy of Cancer(2023)

引用 0|浏览5
暂无评分
关键词
th1/tc1 cell therapy,autologous th1/tc1,cell therapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要